Latest filing published 31 Dec 2012 for ENDOLOGIX INC /DE/, €157k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert John Krist: trading record in brief
Robert John Krist discloses dealings in Endologix Inc /DE/ to SEC (Form 4). Over a trading history stretching from 2 May 2006 to 28 December 2012, the count stands at 66 filings.
In open-market terms, that means 5 purchases worth €299k on one side and 47 sales worth €4.6M on the other. Taken together, the sales exceed the purchases by €4.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 14 share grants. So far in 2012, the count stands at no purchases and 46 sales.
A typical purchase (the median) is worth €20k.
The latest filing, published on 31 December 2012, reports a share grant of €157k in Endologix Inc /DE/. The latest purchase dates back some time: it was published 5,848 days ago, on 4 November 2010. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert John Krist
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,530 shares@ US$5.55Common StockSEC:0001209191-12-059732:0
- 600 shares@ US$14.33Common StockSEC:0001209191-12-059732:1
- 3,930 shares@ US$14.30Common StockSEC:0001209191-12-059732:2
- 3,000 shares@ US$14.20Common StockSEC:0001209191-12-059732:3
- 4,300 shares@ US$14.11Common StockSEC:0001209191-12-059732:4
- 10,000 shares@ US$14.05Common StockSEC:0001209191-12-059732:5
- 211 shares@ US$14.03Common StockSEC:0001209191-12-059732:6
- 10,489 shares@ US$14.00Common StockSEC:0001209191-12-059732:7
- 5,000 shares@ US$13.85Common StockSEC:0001209191-12-059732:8
- 30,000 shares@ US$3.40Common StockSEC:0001209191-12-057472:0
- 4,100 shares@ US$5.55Common StockSEC:0001209191-12-057472:1
- 19,100 shares@ US$5.81Common StockSEC:0001209191-12-057475:0
- 58,370 shares@ US$5.55Common StockSEC:0001209191-12-057475:1
- 2,200 shares@ US$14.07Common StockSEC:0001209191-12-057475:2
- 800 shares@ US$14.06Common StockSEC:0001209191-12-057475:3
- 1,300 shares@ US$14.05Common StockSEC:0001209191-12-057475:4
- 100 shares@ US$14.04Common StockSEC:0001209191-12-057475:5
- 367 shares@ US$14.02Common StockSEC:0001209191-12-057475:6
- 2,394 shares@ US$14.01Common StockSEC:0001209191-12-057475:7
- 6,957 shares@ US$14.00Common StockSEC:0001209191-12-057475:8
- 946 shares@ US$13.99Common StockSEC:0001209191-12-057475:9
- 1,500 shares@ US$13.98Common StockSEC:0001209191-12-057475:10
- 2,294 shares@ US$13.97Common StockSEC:0001209191-12-057475:11
- 1,100 shares@ US$13.96Common StockSEC:0001209191-12-057475:12
- 4,450 shares@ US$13.95Common StockSEC:0001209191-12-057475:13
25 of 64 declarations
